Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality

BACKGROUND: Recently, the type 2 diabetes medication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling and imaging studies of a murin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Kitchener D., Li, Zongjin, Wagner, Roger, Yue, Patrick, Tsao, Phillip, Nestorova, Gergana, Huang, Mei, Hirschberg, David L., Yock, Paul G., Quertermous, Thomas, Wu, Joseph C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481284/
https://www.ncbi.nlm.nih.gov/pubmed/18648539
http://dx.doi.org/10.1371/journal.pone.0002609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481284/
https://www.ncbi.nlm.nih.gov/pubmed/18648539
http://dx.doi.org/10.1371/journal.pone.0002609

Ejemplares similares